Krystal Biotech, a biotechnology company specializing in genetic medicines, announced it will report its third quarter 2026 financial results on November 2, 2026, before U.S. markets open. The company will hold a conference call and webcast at 8:30 am ET the same day to discuss the results and provide a business update. Investors can access the live webcast online, with a replay available for 30 days. This update is important as Krystal Biotech continues to advance its genetic medicine pipeline and commercial products like VYJUVEK® for treating dystrophic epidermolysis bullosa.
Krystal Biotech's upcoming Q3 2026 financial results provide context for health-sector market activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 22, 2026 19:13 WIB: Among 150 priced health-sector US stocks, 63 rose and 79 fell. Quest Diagnostics Inc (DGX) traded at USD 229.99 with a 3.64% decline and a typical hold time of 57 days, contrasting with Summit Therapeutics Inc (SMMT) at USD 15.32 down 3.22% and held typically for 17 days, while Medpace Holdings Inc (MEDP) stood at USD 642.01, down 3.09% with a 15-day hold time.
Flutter Entertainment, a leading online sports betting and iGaming operator, will release its third quarter 2026 update on November 4 before the US market opens. The company will host a conference call at 8:30 a.m. ET the same day to discuss the resu...
iPower Inc. declared a 1-for-12 reverse stock split effective October 26, 2026, combining every 12 shares into one to increase the stock price. This move aims to keep iPower's shares compliant with Nasdaq's minimum bid price requirements. Post-split,...
U.S. Global Investors has listed its actively managed U.S. Global Technology and Aerospace & Defense ETF (WAR) on Peru's Lima Stock Exchange, marking the first availability of this ETF outside the U.S. This move gives Peruvian investors access to a f...
Alignment Health Plan will launch a new Medicare Advantage plan in Pima County starting January 1, 2027, increasing access to affordable, coordinated healthcare for nearly 1.1 million Medicare beneficiaries across Maricopa, Pima, and Santa Cruz count...
The global Urban Air Mobility (UAM) market is projected to grow from $2.16 billion in 2026 to $16.27 billion by 2035, at a CAGR of 20.9%. This growth is fueled by rising urbanization, traffic congestion, and advances in electric vertical takeoff and ...
